Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results
Go back to Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results| (NASDAQ: GLUE) | Delayed: 9.96 -0.16 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.12 | 52 Week High | $ | |||
| Open | $10.18 | 52 Week Low | $ | |||
| Day High | $10.23 | P/E | N/A | |||
| Day Low | $9.88 | EPS | $ | |||
| Volume | 104,640 | |||||



